Berger, J. S., Chen, Y., Kornblith, L., Gong, M., Cushman, M., Kim, K., … Neal, M. D. (2021). P2y12 Inhibitors in Noncritically Ill Hospitalized Patients With Covid-19. In CIRCULATION (Vol. 144, pp. E573–E574).

Berger, Jeffrey S., Yu Chen, Lucy Kornblith, Michelle Gong, Mary Cushman, Keri Kim, Harmony Reynolds, et al. “P2y12 Inhibitors in Noncritically Ill Hospitalized Patients With Covid-19.” In CIRCULATION, 144:E573–74, 2021.

Berger JS, Chen Y, Kornblith L, Gong M, Cushman M, Kim K, et al. P2y12 Inhibitors in Noncritically Ill Hospitalized Patients With Covid-19. In: CIRCULATION. 2021. p. E573–4.

Berger, Jeffrey S., et al. “P2y12 Inhibitors in Noncritically Ill Hospitalized Patients With Covid-19.” CIRCULATION, vol. 144, no. 25, 2021, pp. E573–74.

Berger JS, Chen Y, Kornblith L, Gong M, Cushman M, Kim K, Reynolds H, Lopes RDS, Lopez-Sendon JL, Maggioni A, Antunes MDO, Atassi B, Berry S, Bochicchio G, Farkouh ME, Greenstein Y, Hade E, Hudock K, Kamel H, Khatri P, Kirwan B-A, Kreuziger L, Lawler PR, Leifer E, Maia L, McVerry BJ, Newman JD, Wahid L, Wilson JJ, Wisniewski S, Hochman J, Neal MD. P2y12 Inhibitors in Noncritically Ill Hospitalized Patients With Covid-19. CIRCULATION. 2021. p. E573–E574.